LifeVantage (LFVN) to Release Quarterly Earnings on Thursday

LifeVantage (NASDAQ:LFVN) will be announcing its earnings results after the market closes on Thursday, May 2nd. Investors interested in registering for the company’s conference call can do so using this link.

LifeVantage (NASDAQ:LFVN) last issued its earnings results on Tuesday, January 30th. The company reported $0.10 EPS for the quarter. The business had revenue of $51.62 million during the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%.

LifeVantage Trading Down 2.8 %

Shares of NASDAQ LFVN opened at $6.01 on Tuesday. The business has a fifty day simple moving average of $6.56 and a 200 day simple moving average of $6.39. The firm has a market capitalization of $77.35 million, a price-to-earnings ratio of 26.13 and a beta of 0.78. LifeVantage has a one year low of $3.04 and a one year high of $8.69.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.